Acrivon Therapeutics, Inc. · Brief

Next report

10 days

Nov 12 · after closeest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26—▲+7.56%—

quarterimplied−10%0+10%realized×

Q2 FY26—▲+7.56%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull2

7disclosed supplier and customer ties in SEC filingsSEC filings

45managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

3 of 22largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

ACRV report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.